stella
beta
SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma — Stella
Recruiting
Back to Relapsed or Refractory Hodgkin Lymphoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Han wei dong, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov